| Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
|---|---|---|---|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 1768 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 1805 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 2918 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 3002 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 3399 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 3757 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 5125 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 5572 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 5844 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 5904 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 6016 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 6449 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 7951 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 8126 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 8935 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 11191 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 11253 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 11268 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 12014 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 12103 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 12768 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 14400 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 14854 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 16181 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 16406 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 16695 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 17044 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 17257 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 17874 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 18420 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 18889 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 19255 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 20339 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 21080 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 21470 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 22831 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 24849 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 25405 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 25468 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 25680 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 25718 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 27908 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 28859 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 30004 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 30887 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 32310 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 34735 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 40567 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 43202 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 48418 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | 53044 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
| Reversed phase POSITIVE ION MODE | CYSTATHIONINE (CAS# 56-88-2); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|